Pancreatic Cancer Research

ResearcherStony Brook UniversityActive in the last 2 years

Paolo Boffetta

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3811-2791; OpenAlex author ID A5021007602, A5070587415, A5106022578. Sources: OpenAlex.

Their work

Papers
25 (first author 2, last author 5)
Trials
0
Grants
0
Labs led
1
Collaborators
56
Papers, trials and grants by year

2011: 2 papers · 2012: 5 papers · 2013: 1 paper · 2014: 2 papers · 2015: none · 2016: 6 papers · 2017: 2 papers · 2018: 2 papers · 2019: 2 papers · 2020: 1 paper · 2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 25

  1. Cadmium Exposure and Risk of Pancreatic Cancer: A Systematic Review and Meta-Analysis. Last author DOI 10.23749/mdl.2026.19093↗
  2. Beta-blockers have no impact on survival in pancreatic ductal adenocarcinoma prior to cancer diagnosis. Co-author DOI 10.1038/s41598-020-79999-0↗
  3. Gallbladder disease, cholecystectomy, and pancreatic cancer risk in the International Pancreatic Cancer Case-Control Consortium (PanC4). Co-author DOI 10.1097/cej.0000000000000572↗
  4. Preoperative Endoscopic Retrograde Cholangiopancreatography Is Not Associated With Increased Pancreatic Cancer Mortality. Co-author DOI 10.1016/j.cgh.2018.11.056↗
  5. Age, socioeconomic features, and clinical factors predict receipt of endoscopic retrograde cholangiopancreatography in pancreatic cancer. Co-author DOI 10.4253/wjge.v11.i2.133↗
  6. Opium Use and Risk of Pancreatic Cancer: A Prospective Cohort Study. Co-author DOI 10.1158/1055-9965.epi-17-0592↗
  7. Mutations in Known and Novel cancer Susceptibility Genes in Young Patients with Pancreatic Cancer. Co-author PMID 29940740↗
  8. Dietary acrylamide and the risk of pancreatic cancer in the International Pancreatic Cancer Case-Control Consortium (PanC4). Co-author DOI 10.1093/annonc/mdw618↗
  9. Pancreatic Cancer is Associated with Peripheral Leukocyte Oxidative DNA Damage Co-author DOI 10.22034/apjcp.2017.18.5.1349↗
  10. Adherence to World Cancer Research Fund/American Institute for Cancer Research recommendations and pancreatic cancer risk. Co-author DOI 10.1016/j.canep.2015.10.026↗
  11. Global Trends in Pancreatic Cancer Mortality From 1980 Through 2013 and Predictions for 2017. Co-author DOI 10.1016/j.cgh.2016.05.034↗
  12. Metformin Improves Survival in Patients with Pancreatic Ductal Adenocarcinoma and Pre-Existing Diabetes: A Propensity Score Analysis. Co-author DOI 10.1038/ajg.2016.288↗
  13. Dietary total antioxidant capacity and pancreatic cancer risk: an Italian case-control study. Co-author DOI 10.1038/bjc.2016.114↗
  14. Opium use, cigarette smoking, and alcohol consumption in relation to pancreatic cancer. Co-author DOI 10.1097/md.0000000000003922↗
  15. The Role of Common Pharmaceutical Agents on the Prevention and Treatment of Pancreatic Cancer. First author DOI 10.5009/gnl15451↗
  16. Lack of association between occupational exposure to diesel exhaust and risk of pancreatic cancer: a systematic evaluation of available data. Co-author DOI 10.1007/s00420-013-0892-7↗
  17. Diabetes, antidiabetic medications, and pancreatic cancer risk: an analysis from the International Pancreatic Cancer Case-Control Consortium. Co-author DOI 10.1093/annonc/mdu276↗
  18. Ulcer, gastric surgery and pancreatic cancer risk: an analysis from the International Pancreatic Cancer Case-Control Consortium (PanC4). Co-author DOI 10.1093/annonc/mdt336↗
  19. Pancreatic cancer: overview of descriptive epidemiology. Last author DOI 10.1002/mc.20785↗
  20. Carcinogenesis of pancreatic cancer: challenges, collaborations, progress. First author DOI 10.1002/mc.20876↗
  21. Alcohol consumption and pancreatic cancer: a pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4). Co-author DOI 10.1093/annonc/mdr120↗
  22. Cigarette smoking and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (Panc4). Co-author DOI 10.1093/annonc/mdr541↗
  23. Pancreatitis and pancreatic cancer risk: a pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4). Last author DOI 10.1093/annonc/mds140↗
  24. Cigar and pipe smoking, smokeless tobacco use and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (PanC4). Last author DOI 10.1093/annonc/mdq613↗
  25. Reply to Are cohort data on smokeless tobacco use and pancreatic cancer confounded by alcohol use? Last author DOI 10.1093/annonc/mdr305↗

Closest collaborators

The 25 strongest of 56 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Aimee Lee Lucas · 8 shared papers, 2016–2021 · strength 0.70
  2. Carlo La Vecchia · 13 shared papers, 2011–2020 · strength 0.52
  3. Sunil Amin · 5 shared papers, 2016–2021 · strength 0.51
  4. Cristina Bosetti · 12 shared papers, 2011–2020 · strength 0.49
  5. Monireh Sadat Seyyedsalehi · 1 shared paper, 2026 · strength 0.43
  6. Eva Negri · 10 shared papers, 2011–2020 · strength 0.37
  7. Sheila D. Rustgi · 3 shared papers, 2019–2021 · strength 0.35
  8. Jerry Polesel · 9 shared papers, 2011–2017 · strength 0.31
  9. Eric J. Duell · 9 shared papers, 2011–2020 · strength 0.29
  10. Gloria M. Petersen · 8 shared papers, 2011–2020 · strength 0.28
  11. Akram Pourshams Md · 4 shared papers, 2016–2018 · strength 0.26
  12. Anthony Yang · 2 shared papers, 2019–2021 · strength 0.24
  13. H. Bas Bueno-de-Mesquita · 8 shared papers, 2011–2020 · strength 0.24
  14. Patrick Maisonneuve · 8 shared papers, 2011–2020 · strength 0.24
  15. Sara H. Olson · 7 shared papers, 2011–2020 · strength 0.22
  16. Elizabeth T. H. Fontham · 8 shared papers, 2011–2017 · strength 0.21
  17. Ersilia Lucenteforte · 8 shared papers, 2011–2017 · strength 0.21
  18. Paige M. Bracci · 8 shared papers, 2011–2017 · strength 0.21
  19. Ashraf Mohamadkhani · 3 shared papers, 2016–2018 · strength 0.20
  20. Satish Nagula · 2 shared papers, 2019 · strength 0.20
  21. Dali Li · 7 shared papers, 2011–2017 · strength 0.18
  22. Reza Malekzadeh Md · 3 shared papers, 2016–2018 · strength 0.18
  23. Valentina Rosato · 3 shared papers, 2014–2020 · strength 0.17
  24. Moustapha Hassan · 6 shared papers, 2011–2017 · strength 0.16
  25. Parviz Ghadirian · 7 shared papers, 2011–2014 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.